undefined

Quang Pham

Founder, Chairman and CEO of Cadrenal Therapeutics. He discusses the impact of NIH budget cuts on his company's ability to conduct pre-clinical research on new drugs.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app